Location History:
- Lichtaart, BE (2011)
- The Netherlands, BE (2011)
- Boxmeer, NL (2012 - 2024)
Company Filing History:
6 out of 2,925 
6 out of 1,521 
6 out of 3,439 
Years Active: 2011-2024
Title: Daniel Ghislena Emiel Goovaerts: Innovator in Canine Respiratory Disease Control
Introduction:
In the world of innovations and patents, there are individuals who make significant contributions to various fields. One such innovator is Daniel Ghislena Emiel Goovaerts, hailing from Boxmeer, Netherlands. With a total of eight patents to his name, Goovaerts has made noteworthy advancements in the area of respiratory disease control in canines. Let's delve deeper into his latest patents, career highlights, collaborations, and conclude by acknowledging his valuable contributions.
Latest Patents:
Daniel Goovaerts' latest patents revolve around materials and methods for respiratory disease control in canines. In particular, his inventions focus on isolated influenza viruses capable of infecting canids and causing respiratory diseases. The patented compositions and methods aim to induce an immune response against these influenza viruses, aiding in disease control and prevention. Furthermore, these inventions encompass the identification and diagnosis of infection in animals caused by these particular viruses.
Career Highlights:
Goovaerts has been associated with esteemed institutions such as the University of Florida Research Foundation, Incorporated, and Cornell Research Foundation Inc. during his career. His work in the field of respiratory disease control in canines has brought him recognition and accolades. Through his patents, his research has demonstrated its potential to facilitate advancements in veterinary medicine by addressing the health concerns of affected canids. Goovaerts' commitment to animal welfare is evident in his endeavors to combat respiratory diseases that impact canines.
Collaborations:
Innovation often flourishes through collaboration, and Goovaerts has had the opportunity to work with notable individuals in his field, including Melissa Anne Lum and Mark William Mellencamp. By joining forces with these talented professionals, Goovaerts has amplified his impact and contributed to the collective knowledge and expertise within the realm of respiratory disease control in canines.
Conclusion:
Daniel Ghislena Emiel Goovaerts, a distinguished innovator in the field of veterinary medicine, has made significant contributions to the control and prevention of respiratory diseases in canines. With his eight patents, he has pioneered materials and methods that target influenza viruses affecting canids, thereby offering promising solutions to safeguard their health. His collaborations with esteemed institutions and fellow experts reinforce the importance of cooperation to drive innovation forward. Daniel Goovaerts' dedication to creating a positive impact in animal healthcare is commendable, and his endeavors serve as an inspiration for aspiring inventors and researchers in the field.